These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 855721)

  • 1. Adenine and adenosine metabolism in lymphocytes deficient in adenosine deaminase (ADA) activity.
    Raivio KO; Schwartz AL; Stern RC; Polmar SH
    Adv Exp Med Biol; 1977; 76A():456-62. PubMed ID: 855721
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenine and adenosine metabolism in phytohemagglutinin (PHA) - stimulated and unstimulated normal human lymphocytes.
    Raivio KO; Hovi T
    Adv Exp Med Biol; 1977; 76A():448-55. PubMed ID: 855720
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.
    Coleman MS; Donofrio J; Hutton JJ; Hahn L; Daoud A; Lampkin B; Dyminski J
    J Biol Chem; 1978 Mar; 253(5):1619-26. PubMed ID: 627559
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenosine deaminase deficiency in combined immunologic deficiency disease.
    Meuwissen HJ; Pickering RJ; Pollara B
    Birth Defects Orig Artic Ser; 1975; 11(1):117-9. PubMed ID: 1148375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The function of adenosine deaminase in the human erythrocyte.
    Perrett D; Dean B
    Biochem Biophys Res Commun; 1977 Jul; 77(1):374-8. PubMed ID: 883983
    [No Abstract]   [Full Text] [Related]  

  • 6. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
    Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactive adenosine deaminase (ADA) in cultured fibroblasts from patients with combined immunodeficiency disease.
    Carson DA; Goldblum R; Keightley R; Seegmiller JE
    Adv Exp Med Biol; 1977; 76A():463-70. PubMed ID: 855722
    [No Abstract]   [Full Text] [Related]  

  • 8. Nucleotide levels and metabolism of adenosine and deoxyadenosine in intact erythrocytes deficient in adenosine deaminase.
    Webster DR; Simmonds HA; Perrett D; Levinsky RJ
    Adv Exp Med Biol; 1984; 165 Pt A():363-6. PubMed ID: 6609529
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenosine deaminase and immunodeficiency.
    Cohen F
    Birth Defects Orig Artic Ser; 1975; 11(1):124-7. PubMed ID: 1148377
    [No Abstract]   [Full Text] [Related]  

  • 10. Demonstration of adenosine receptor on human lymphocytes in vitro and its possible role in the adenosine deaminase-deficient form of severe combined immunodeficiency.
    Schwartz AL; Stern RC; Polmar SH
    Clin Immunol Immunopathol; 1978 Apr; 9(4):499-505. PubMed ID: 206401
    [No Abstract]   [Full Text] [Related]  

  • 11. A lymphoblastoid cell line from an adenosine deaminase deficient patient established by Epstein-Barr virus.
    Tsuchiya S; Narisawa K; Konno T; Tada K
    Tohoku J Exp Med; 1979 Oct; 129(2):105-10. PubMed ID: 227140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal platelet aggregation in severe combined immunodeficiency disease with adenosine deaminase deficiency.
    Schwartz AL; Polmar SH; Stern RC; Cowan DH
    Br J Haematol; 1978 Jun; 39(2):189-94. PubMed ID: 678472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.
    Agarwal RP; Crabtree GW; Parks RE; Nelson JA; Keightley R; Parkman R; Rosen FS; Stern RC; Polmar SH
    J Clin Invest; 1976 Apr; 57(4):1025-35. PubMed ID: 947948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited effect of erythrocyte and plasma infusions in adenosine deaminase deficiency.
    Schmalstieg FC; Mills GC; Nelson JA; May LT; Goldman AS; Goldblum RM
    J Pediatr; 1978 Oct; 93(4):597-603. PubMed ID: 308999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purine metabolism in adenosine deaminase deficiency.
    Mills GC; Schmalstieg FC; Trimmer KB; Goldman AS; Goldblum RM
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2867-71. PubMed ID: 1066699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purine dysfunction in cells from patients with adenosine deaminase deficiency.
    Benke PJ; Dittmar D
    Pediatr Res; 1976 Jul; 10(7):642-6. PubMed ID: 132630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
    Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
    Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenosine deaminase deficiency and severe combined immunodeficiency disease.
    Thompson LF; Seegmiller JE
    Adv Enzymol Relat Areas Mol Biol; 1980; 51():167-210. PubMed ID: 6255772
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
    Ullman B; Cohen A; Martin DW
    Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase and immune dysfunction. Biochemical correlates defined by molecular analysis throughout a disease course.
    Coleman MS; Danton MJ; Philips A
    Ann N Y Acad Sci; 1985; 451():54-65. PubMed ID: 3878121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.